[ad_1]
CAMAGÜEY.- With 28 years of existence, the Center for Genetic Engineering and Biotechnology (CIGB) of this province stands out as the entity for the development and manufacture of agricultural products in the biotechnology system in Cuba. [19659002] Gavac vaccines against cattle ticks, and Porvac against porcine cholera, and Hebernem bionematicide for the control of nematodes in protected culture houses, are the drugs currently marketed in Cuba under the brand name of this scientific institution.
Yamilka Ramírez Núñez, a leading specialist in ICOLD's Commercial Group in the territory, explains that one million and a half million doses of de Gavac, the center's flagship product, were billed until July, a little more than half of the year's plan.
The national scope of Gavac was 900,000 cattle until the end of 2017, certified by the Department of Animal Health of the Ministry of Agriculture, a figure that should be increased at the end of In the first half of this year, thanks to the first vaccination campaign of the calendar
In the case of Porvac, a vaccine recently recorded in the basic table of veterinary drugs in the country, it is already applied in nine provinces and near 760,000 doses were released, mainly aimed at multipliers and genetic units of the national hog industry.
Yamilka Ramírez added that nearly 1,500 units or bags were marketed in Hebernem, for culture houses across Cuba, although they also carry out studies of the introduction of the bioproduct into plantations in outdoors.
Nemesio González Fernández, head of the research and development department of the CIGB in Camagüey, explained that the entity, within the Cuban biotechnology system, headed by the CIGB of Havana, is in charge of the development of technology and production. formulations for agricultural and veterinary use.
4The CIGB in Camagüey has three plants, one for the fermentation of bacteria and yeasts, for the purification and formulation of vaccines, where the three products are involved at a stage of their production. , another plant for mammalian cell culture for Porvac, and another for the formulation of bioproducts such as Hebernem.
Acotó González says that in Camagüey the development of technologies and the production of project results that are studied in the IGBC are supposed. Havana and in the territory itself, at the moment focused mainly on the research of bioproducts to cover a wide range of agricultural diseases.
Inaugurated on July 25, 1989, when the commander of the Cuban Revolution, Commander-in-Chief Fidel Castro, visited newly built facilities, Camagüey's CIGB maintains the premise of creating high-value-added biotechnology components in a closed cycle. export and import substitution
Source link
